Clinical Guides
Iron Deficiency Anaemia — Diagnosis, Cause Finding and Treatment
A clinically focused clinical guide to confirming iron deficiency, identifying why it occurred, restoring iron safely, and preventing recurrent anaemia in Indian practice.
MedNext Academy | 14 min read
Iron Deficiency Anaemia — Diagnosis, Cause Finding and Treatment
A clinically focused clinical guide to confirming iron deficiency, identifying why it occurred, restoring iron safely, and preventing recurrent anaemia in Indian practice.
Summary
Iron deficiency anaemia (IDA) means that haemoglobin is below the appropriate reference threshold and insufficient available iron is contributing to impaired erythropoiesis. Iron deficiency can exist before anaemia develops, and anaemia has many causes other than iron deficiency. Microcytosis and pallor are clues, not diagnoses. Safe practice confirms the blood-count pattern, interprets ferritin and other iron indices in clinical context, and searches for the reason iron has been depleted. Giving tablets without cause finding can temporarily improve haemoglobin while gastrointestinal cancer, heavy menstrual bleeding, coeliac disease, parasitic blood loss or another important disorder remains untreated.
Common mechanisms are chronic blood loss, increased requirement, inadequate bioavailable intake and malabsorption. More than one can coexist. Menstrual and pregnancy-related demand are important in younger women; gastrointestinal blood loss deserves particular attention in adult men, postmenopausal women and anyone with alarm symptoms. Children, pregnancy, chronic kidney disease, heart failure and inflammatory bowel disease have population-specific thresholds and treatment pathways and should not be forced into one adult algorithm.
Management combines treatment of the cause with iron replacement. An oral iron salt is appropriate for many stable patients; formulation, elemental iron, frequency, tolerance and adherence should be reviewed rather than assuming failure. Intravenous iron is useful when oral treatment is ineffective, not tolerated, unlikely to be absorbed, or when rapid repletion is clinically necessary. Red-cell transfusion does not replenish iron stores and is reserved for selected severe symptomatic or circulatory presentations. This guide does not provide an individual dose. Every plan needs response monitoring, safety-netting and current Indian product or programme verification. Publication remains quarantined until MedNext Clinical Team review.
How Common Is It?
Anaemia is a major public-health problem in India, and iron deficiency is an important contributor, but anaemia prevalence is not the same as IDA prevalence. Haemoglobin measurement alone cannot assign cause. National surveys may report anaemia by age, sex or reproductive group; those estimates depend on sampling, altitude adjustment, device quality, threshold definitions and survey year. Iron-status measurements are less often available at population scale. It is therefore inaccurate to convert every national anaemia percentage into a number of people with iron deficiency.
IDA occurs across the life course. Risk is high during infancy and rapid childhood growth, adolescence, menstruation and pregnancy, and it also affects adult men and older adults through gastrointestinal or other chronic blood loss, malabsorption, restrictive diets and illness. The proportion attributable to each mechanism varies by region and setting. Rural and urban differences may reflect diet, infection, menstrual health, maternity care, sanitation, poverty, inflammation and access to testing rather than a single deficiency pathway.
The clinical burden extends beyond a haemoglobin result. Fatigue, reduced exercise tolerance, impaired concentration, restless legs and pregnancy or developmental consequences can occur, while slowly developing severe anaemia may be deceptively well tolerated at rest. Conversely, symptom intensity is influenced by speed of onset, cardiopulmonary reserve and comorbidity. Public-health programmes appropriately emphasise prevention, supplementation, deworming and case detection in defined groups. Individual clinical care must still confirm severity, identify red flags and investigate an unexpected or recurrent pattern. This guide avoids a fixed prevalence number because programme pages and surveys update, and because no single figure is an adequate diagnostic shortcut.
Risk Factors
Chronic blood loss is a leading cause. Ask specifically about heavy or prolonged menstruation, intermenstrual or postcoital bleeding, postpartum loss, melaena, rectal bleeding, haematemesis, haematuria, recurrent epistaxis, blood donation and surgical or traumatic loss. Gastrointestinal bleeding may be occult and arise from ulcer disease, cancer, inflammatory bowel disease, vascular lesions, parasites or medicine-related mucosal injury. Non-steroidal anti-inflammatory drugs, antiplatelet agents and anticoagulants can expose or worsen bleeding but should not be accepted as the complete explanation without assessing the source.
Requirement rises with growth and pregnancy. Low-birth-weight or premature infants start with different stores; toddlers with limited iron-rich complementary food and adolescents with growth plus menstruation are vulnerable. Low intake risk depends on food quantity, bioavailability and meal pattern, not vegetarian identity alone. Tea or coffee with meals, high-phytate diets, food insecurity, restrictive eating and excessive cow's milk in young children can contribute. Malabsorption follows coeliac disease, inflammatory bowel disease, autoimmune gastritis, Helicobacter pylori-associated disease in selected cases, gastric or small-bowel surgery and some chronic medicines.
Inflammation, chronic kidney disease and heart failure can create functional iron restriction and make ferritin harder to interpret. Hookworm and malaria are regionally relevant in India, while thalassaemia and other haemoglobinopathies can cause microcytosis without iron depletion; either may coexist with deficiency. Recurrent or lifelong refractory disease raises rare inherited iron-handling disorders but common explanations—incorrect diagnosis, inadequate elemental intake, poor tolerance, continued bleeding and non-adherence—should be assessed respectfully first. Social risks include unaffordable investigations, fragmented care, lack of menstrual privacy and unregulated combination tonics whose elemental iron content is unclear.
Diagnosis
History
Establish onset and trajectory of fatigue, dyspnoea, palpitations, dizziness, syncope, headache, cognitive difficulty, pica, restless legs, reduced work capacity and chest pain. Ask about every plausible blood-loss route, menstrual quantity and pregnancy, diet, gastrointestinal symptoms, bowel change, weight loss, dysphagia, pain, diarrhoea, donation, surgery and medicines. Record infection, inflammation, renal disease, family haemoglobinopathy, previous counts, iron treatment, response and adverse effects. In children assess growth, feeding, development and geophagia.
Examination
Assess pulse, blood pressure, respiratory rate, oxygenation, perfusion and signs of cardiac strain. Look for conjunctival or palmar pallor, angular cheilitis, glossitis, brittle or spooned nails, jaundice, bruising, lymph nodes, oedema and malnutrition. Examine the heart for tachycardia, flow murmur or failure; abdomen for tenderness, mass or hepatosplenomegaly. Perform rectal, pelvic or other intimate examination only when indicated, with consent, privacy and a chaperone under local policy. Pallor is neither sensitive nor specific enough to quantify anaemia.
Investigations
Start with complete blood count including red-cell indices, reticulocyte count and peripheral smear. Confirm iron status with ferritin; add transferrin saturation, C-reactive protein or other markers when inflammation can mask depleted stores. Serum iron alone varies and should not diagnose IDA. Microcytosis, hypochromia, anisocytosis and pencil cells support deficiency, but normal MCV does not exclude early or mixed disease. Test pregnancy where relevant. Cause-directed tests may include coeliac serology with total IgA, stool or parasite evaluation, urinalysis, endoscopy, gynaecological assessment and haemoglobin analysis. Adult gastrointestinal investigation depends on age, sex, symptoms, cancer risk and local access. A therapeutic response can support deficiency but must not replace investigation of a concerning cause.
Differential Diagnosis
Thalassaemia trait is a central alternative in India. It can produce marked microcytosis with relatively preserved haemoglobin and a comparatively high red-cell count; ferritin is not depleted unless iron deficiency coexists. Haemoglobin analysis is considered when microcytosis is disproportionate, family or ethnic history supports risk, or iron studies are normal. Empirical iron given indefinitely to a carrier provides no benefit and can obscure counselling. Other microcytic causes include anaemia of inflammation, sideroblastic anaemia and lead toxicity. The blood film and iron profile narrow the pattern but do not replace exposure and clinical history.
Anaemia of inflammation or chronic disease often shows restricted circulating iron with normal or increased ferritin because ferritin is an acute-phase reactant and hepcidin limits iron availability. Absolute and functional deficiency can coexist in renal disease, inflammatory bowel disease, infection, cancer and heart failure. Reticulocyte haemoglobin, transferrin saturation, inflammatory markers and response to treatment may help when routine indices disagree. Bone-marrow iron assessment is rarely necessary solely to diagnose ordinary IDA.
Macrocytic vitamin B12 or folate deficiency can coexist and yield a normal MCV that hides both processes. Haemolysis is suggested by jaundice, raised reticulocytes and appropriate biochemical evidence; marrow failure by cytopenias, low reticulocytes, abnormal cells, bone pain or organomegaly. Acute bleeding may initially be normocytic. Pregnancy-related haemodilution, renal erythropoietin deficiency, endocrine disease and inherited red-cell disorders need mechanism-specific evaluation. A low haemoglobin plus low ferritin usually establishes depleted stores, but the clinician must still ask why. Failure to respond should reopen adherence, continuing loss, absorption, inflammation and the original diagnosis rather than trigger automatic dose escalation.
Management
Treat physiological instability or active bleeding first. A stable patient needs two linked plans: replace iron and identify or stop the loss. Manage heavy menstrual bleeding, gastrointestinal disease, parasites, malabsorption, dietary insufficiency or donation practices through the appropriate pathway. Do not postpone iron unnecessarily while routine investigation proceeds, but preserve diagnostic samples and coordinate timing when endoscopy or surgery is imminent. Food advice supports recovery but usually cannot replace therapeutic iron once clinically significant IDA is established.
For many adults, a standard ferrous salt providing a verified amount of elemental iron once daily is a reasonable starting approach. Lower-frequency or alternate-day dosing can improve tolerance and absorption for some people. Explain how the chosen product should be taken, which adverse effects are expected, and what to do rather than silently stopping. Tea, coffee, calcium and antacids around administration may reduce absorption; rigid fasting instructions are counterproductive if nausea makes adherence impossible. In children and pregnancy, use age-, weight- and gestation-specific protocols.
Review symptoms, adherence and haemoglobin response within a defined early interval, commonly two to four weeks depending on severity and regimen. Continue long enough after haemoglobin correction to replenish stores, then confirm that recurrence has not occurred. Intravenous iron is considered when oral iron is ineffective or intolerable, absorption is impaired, ongoing loss outpaces replacement, or timely repletion is needed. Choose formulation and total requirement under a monitored protocol. Red-cell transfusion is not routine treatment for stable chronic IDA; if severe symptoms or circulatory compromise require it, iron replacement remains necessary. Persistent or recurrent IDA warrants renewed cause finding, not permanent supplementation without explanation.
Prescribing Information
Prescribe by elemental iron, not tablet colour or salt weight alone. Ferrous sulphate, fumarate and gluconate products contain different amounts, and Indian brands or fixed-dose combinations vary. Verify the current label and avoid duplicating iron in multivitamins or tonics. The regimen depends on age, pregnancy, severity, tolerance, inflammation, kidney function and urgency. This guide deliberately omits a universal dose because applying an adult tablet schedule to a child or confusing salt mass with elemental iron can cause harm.
Oral iron commonly causes nausea, epigastric discomfort, constipation, diarrhoea and dark stool. Dark stool is expected but must not automatically dismiss true melaena. Liquid preparations can stain teeth; dilution and appropriate administration advice may help. Keep all products out of children's reach because acute overdose is life-threatening. Review interactions with antacids, calcium, levothyroxine, tetracyclines, quinolones and other medicines; separate administration according to verified product guidance. Vitamin C is not mandatory for every patient, and unregulated haematinics should not replace a known formulation.
Intravenous iron requires confirmation of indication, calculation of deficit or protocol dose, infection and allergy review, reliable venous access, trained observation and resuscitation readiness. Formulations differ in maximum single dose, infusion time, hypophosphataemia risk and reaction management. A prior reaction needs specialist assessment rather than automatic permanent exclusion or casual rechallenge. Avoid giving oral and intravenous products simultaneously without a plan.
Transfusion follows local blood policy and clinical physiology; one unit does not correct the underlying iron deficit. Pregnancy, paediatrics, chronic kidney disease, heart failure and inflammatory bowel disease each have dedicated guidance. Every prescription needs a follow-up date, expected response, duration after correction, adverse-effect plan and explicit action if haemoglobin fails to rise.
When to Refer
Refer urgently or admit when anaemia is associated with haemodynamic instability, active major bleeding, syncope, chest pain, heart failure, severe breathlessness, hypoxia, altered consciousness or rapid deterioration. The decision depends on symptoms, rate of fall and cardiopulmonary reserve, not a haemoglobin value alone. Suspected gastrointestinal or gynaecological malignancy, pregnancy complication or bleeding disorder follows the relevant urgent pathway. Severe childhood anaemia, failure to thrive, developmental concern or cardiorespiratory signs needs paediatric assessment.
Adult men and postmenopausal women with newly confirmed IDA generally require gastrointestinal cause assessment unless a clear alternative has been established. Premenopausal women also need referral when symptoms, age, family history, recurrent or disproportionate deficiency, bowel change, weight loss, coeliac features or treatment failure raises concern; menstruation must not become a blanket explanation. Refer to gastroenterology for indicated bidirectional endoscopy or recurrent unexplained disease, and to gynaecology for heavy, irregular or postcoital bleeding, pelvic symptoms or structural suspicion.
Haematology input is appropriate for unexplained cytopenias, abnormal cells, haemolysis, organomegaly, suspected marrow disease, diagnostic conflict, haemoglobinopathy, severe refractory deficiency or a possible inherited iron disorder. Renal, cardiac, inflammatory-bowel and obstetric teams should manage disease-specific iron pathways. Dietetic support is useful for restrictive diets, food insecurity, malnutrition or bariatric surgery.
A useful referral includes symptom and bleeding chronology, menstrual and pregnancy status, complete blood-count trends, reticulocytes, smear, ferritin, transferrin saturation, inflammatory markers, renal and liver tests, coeliac testing if done, relevant stool or urine results, prior iron formulation and elemental amount, adherence, response, comorbidity and medicines. Referral should not leave active symptoms or iron replacement unowned.
Red Flags
Emergency features are collapse, hypotension, marked tachycardia, confusion, chest pain, breathlessness at rest, hypoxia, pulmonary oedema, inability to stand, ongoing haematemesis, melaena, heavy vaginal bleeding or other active haemorrhage. Establish intravenous access and assess circulation under the local emergency pathway. A person with chronic adaptation can appear surprisingly comfortable despite profound anaemia, while someone with coronary disease can become ischaemic at a less extreme value. Treat physiology and cause rather than waiting for a laboratory threshold.
Alarm features requiring rapid cause investigation include unintentional weight loss, progressive dysphagia, persistent vomiting, new bowel change, abdominal or pelvic mass, rectal bleeding, postmenopausal bleeding, recurrent fever, night sweats, bone pain, lymphadenopathy and hepatosplenomegaly. Pancytopenia, circulating blasts, severe thrombocytopenia, jaundice with haemolysis or neurological change points beyond uncomplicated iron deficiency. Pica can expose a patient to lead or infection and should be explored without ridicule.
During oral treatment, severe abdominal pain, repeated vomiting, suspected overdose, allergic symptoms or true gastrointestinal bleeding requires urgent assessment. Any possible iron ingestion by a young child is a poison emergency; do not wait for symptoms or induce vomiting. During intravenous iron, wheeze, hypotension, facial or airway swelling, collapse or severe chest symptoms requires immediate infusion cessation and emergency response by trained staff.
Failure to improve is a safety signal when adherence and adequate treatment are documented. Continued loss, cancer, coeliac disease, inflammation, haemoglobinopathy, wrong preparation or a mixed deficiency may be present. Patients need written return triggers and a named clinician responsible for reviewing results; telling them merely to finish tablets can allow a serious source to progress.
Indian Clinical Context
India's Anaemia Mukt Bharat strategy appropriately uses life-course prevention, iron-folic acid supplementation, deworming, behaviour change, testing and attention to non-nutritional causes in defined beneficiary groups. Those programme doses and schedules are not interchangeable with treatment of a clinically diagnosed individual. A point-of-care haemoglobin result can identify anaemia but does not prove iron deficiency. A clinician must distinguish programme prevention, facility treatment and specialist management, particularly in severe, recurrent or atypical cases.
Local causation is diverse. Dietary bioavailability, menstrual health, pregnancy, closely spaced births, hookworm, malaria, tuberculosis or other inflammation, coeliac disease, gastrointestinal cancer, haemoglobinopathies and medicine-related bleeding can overlap. Deworming without epidemiological relevance or iron without confirmation can both miss the diagnosis. In regions with thalassaemia or sickle-cell prevalence, persistent microcytosis with normal stores needs haemoglobin analysis and appropriate counselling. Ferritin access may be limited; when it is unavailable, document uncertainty, use the best available indices and therapeutic response, and refer rather than claiming certainty.
Costs, travel, stigma around menstrual history, vegetarian dietary assumptions and variable product quality affect care. Ask what the person actually eats, whether they can obtain and tolerate the product, and whether investigations are feasible. Use low-cost familiar foods to improve intake, but do not promise that beetroot, jaggery or a single food will correct established IDA. Tea timing and parasitic exposure may be modifiable, while food insecurity requires system support rather than blame.
WHO and BSG guidance provide evidence frameworks but are not Indian law or uniform service policy. BSG endoscopy pathways reflect UK resources. Indian teams should use current national or institutional protocols, local cancer pathways, laboratory ranges and drug labels. This guide claims no one national dose and remains reviewed following MedNext Clinical Team review.
NMC Competency Mapping
NMC CBME Curriculum 2024 pathology competencies PA14.1, PA14.2 and PA14.3 provide direct anchors. PA14.1 covers iron metabolism; PA14.2 covers aetiology, investigations and differential diagnosis of microcytic hypochromic anaemia; PA14.3 covers identification and description of the peripheral smear. General-medicine anaemia competencies in the IM9 module extend this foundation to clinical history, examination, investigation, severity assessment, management and communication. Paediatric and obstetric learning require their own age- and pregnancy-specific integration.
A graduating learner should explain absorption, transport, storage, recycling and hepcidin regulation; distinguish iron depletion from iron-restricted erythropoiesis; and interpret ferritin with inflammation. They should recognise microcytosis, hypochromia, anisopoikilocytosis and pencil forms without calling morphology pathognomonic. A good differential contrasts IDA with thalassaemia trait, inflammation, sideroblastic disease and lead toxicity using the complete count, red-cell number, smear and iron indices.
Clinical competence includes asking respectfully about menstruation, pregnancy, gastrointestinal bleeding, diet, parasites, donation and medicines; assessing cardiorespiratory instability; identifying a cause-finding plan; counselling on elemental iron and adverse effects; and defining follow-up. Students should understand that treatment response can support diagnosis but never cancels alarm-feature investigation. They should distinguish population prophylaxis from therapeutic replacement.
Curriculum mapping does not authorise independent endoscopy, intravenous iron, transfusion, paediatric dose calculation or management of active haemorrhage. These require supervision and local protocols. Assessment should reward mechanism, red-flag recognition, exact product interpretation and follow-up ownership rather than memorising one ferritin threshold or salt dose for all populations. Formal code wording should be reconciled with the current institutional NMC ledger.
Key Exam Pearls for NEET PG
Iron deficiency progresses from depleted stores to iron-restricted erythropoiesis and finally anaemia. Ferritin is the most useful storage marker in the absence of inflammation; it can be falsely normal or elevated as an acute-phase reactant. Transferrin saturation and inflammatory markers help when clinical suspicion remains. Serum iron alone fluctuates and is inadequate. The typical pattern is low haemoglobin, low MCV and MCH, raised red-cell distribution width, depleted ferritin and increased iron-binding capacity, but early or mixed deficiency may be normocytic.
The film can show microcytic hypochromic cells, anisopoikilocytosis and pencil cells. Thalassaemia trait often has microcytosis out of proportion to anaemia, a relatively high red-cell count and non-depleted stores; haemoglobin analysis is appropriate rather than endless iron. Anaemia of inflammation commonly has low circulating iron with preserved or raised ferritin. Coexisting B12 or folate deficiency can normalise MCV. Reticulocyte and haemoglobin response after treatment supports effective erythropoiesis.
Always name the cause. Heavy menstrual bleeding is common, but adult men, postmenopausal women and patients with alarm features need gastrointestinal evaluation. Coeliac disease, NSAID injury, cancer, blood donation, pregnancy, hookworm and poor intake are high-yield mechanisms. Plummer-Vinson syndrome links IDA, dysphagia and an oesophageal web and requires evaluation rather than iron alone.
Oral ferrous salts are first-line for many stable adults; think elemental iron, tolerability and adherence. Intravenous iron is for defined indications. Transfusion is reserved for severe symptomatic or circulatory compromise and does not replenish stores. In exams retain PA14.1-PA14.3 and the IM9 clinical approach: confirm the pattern, stabilise danger, locate the loss, replace iron, document response and reopen the diagnosis if treatment fails.
Frequently Asked Questions
Does a low haemoglobin automatically mean iron deficiency anaemia?
No. Anaemia describes a haemoglobin below the appropriate threshold, while iron deficiency is one possible mechanism. Blood count indices, ferritin and sometimes transferrin saturation, inflammation markers, smear or other tests are needed. Thalassaemia, inflammation, kidney disease, B12 or folate deficiency, haemolysis, bleeding and marrow disease can cause or coexist with anaemia. Cause assignment matters because iron alone may be ineffective or delay a serious diagnosis.
Can iron deficiency anaemia be treated with diet alone?
Dietary improvement helps prevent recurrence and may correct very early deficiency, but established clinically important IDA usually needs a verified therapeutic iron preparation as well as treatment of the cause. Food advice should be specific to the person's meals, budget and absorption barriers. Beetroot, jaggery or one advertised food is not a substitute for adequate elemental iron. Severe symptoms, pregnancy, childhood disease or ongoing blood loss require clinician-led care.
Why can ferritin look normal even when iron is deficient?
Ferritin reflects iron stores but also rises during inflammation, infection, liver disease and some cancers. A value that appears normal can therefore mask absolute deficiency. The clinician may interpret it with C-reactive protein, transferrin saturation, reticulocyte haemoglobin, clinical context and response to iron. Thresholds also differ by population and comorbidity. Serum iron by itself is variable and does not solve this problem.
What should be checked when haemoglobin does not rise after iron treatment?
First verify the diagnosis, actual elemental iron, adherence, timing, tolerance and whether the product was taken with absorption inhibitors. Then reassess continuing menstrual or gastrointestinal loss, coeliac or other malabsorption, inflammation, kidney disease, parasites, thalassaemia, mixed B12 or folate deficiency and marrow disease. Non-response should trigger structured review, not automatic dose escalation or indefinite switching between tonics.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic